-
Kawasaki-like syndrome linked to coronavirus is new condition
pharmatimes
June 09, 2020
Researchers have found that the Kawasaki-like syndrome reported in some children with coronavirus is actually a new inflammatory condition.
-
Shanghai Junshi Biosciences starts human tests for coronavirus antibody drug
expresspharma
June 08, 2020
The experimental drug, JS016, is also expected to begin human study in the US in the second quarter of this year, through collaboration with Eli Lilly and Co.
-
Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope
expresspharma
June 08, 2020
Based on evidence from laboratory, animal and clinical studies, it has generated promising results in MERS-CoV and SARS which are also caused by corona virus, tweeted Tope.
-
NCVTC to develop host-directed antivirals for COVID 19
expresspharma
June 05, 2020
The selected candidates (hits) with anti-coronavirus activity will be subjected to study of their molecular mechanism of action, besides examining generation of potential drug-resistant virus variants.
-
Simple but effective: an experimental nanoparticle COVID-19 test
europeanpharmaceuticalreview
June 03, 2020
Researchers reveal their experimental test can detect the presence of COVID-19 RNA in a sample in 10 minutes, and in a way that does not require trained personnel to interpret.
-
New coronavirus losing potency, top Italian doctor says
expresspharma
June 02, 2020
Italy has the third highest death toll in the world from COVID-19, with 33,415 people dying since the outbreak came to light on Feb. 21. It has the sixth highest global tally of cases at 233,019.
-
30 countries launch initiative to share COVID-19 tools
expresspharma
June 02, 2020
It comes amid concerns that rich countries pumping resources into finding will muscle their way to the front of the queue, once a candidate succeeds.
-
Celltrion says COVID-19 drug shows drop in viral load in animal testing
expresspharma
June 02, 2020
Celltrion has research experience with other types of coronavirus conditions such as Middle East Respiratory Syndrome (MERS).
-
CordenPharma & Moderna Extend Manufacturing Agreement
contractpharma
June 01, 2020
For the supply of lipid excipients to be used in Moderna's coronavirus vaccine.
-
AstraZeneca says it may consider exposing vaccine trial participants to virus
expresspharma
June 01, 2020
The British drugmaker last week started phase 2 and 3 trials of the vaccine, looking to recruit around 10,000 adults and children in Britain.